S.I. No. 44/1996 - Irish Medicines Board (Fees) Regulations, 1996.


S.I. No. 44 of 1996.

IRISH MEDICINES BOARD (FEES) REGULATIONS, 1996.

In exercise of the powers conferred on the Minister for Health Section 13 of the Irish Medicines Board Act, 1995 (No. 29 of 1995), which said powers are delegated to me by the Health (Delegation of Ministerial Functions) Order, 1996 ( S.I. No. 24 of 1996 ), I, BRIAN O'SHEA, Minister of State at the Department of Health, hereby make the following Regulations:—

1. These Regulations may be cited as the Irish Medicines Board (Fees) Regulations, 1995.

2. In these Regulations—

"the Act" means the Irish Medicines Board Act, 1995 .

"the Board" means the Irish Medicines Board,

"manufacturing licence" means a licence granted pursuant to the Medical Preparations (Licensing of Manufacture) Regulations, 1993—1996,

"the Minister" means the Minister for Health,

"product authorisation" means an authorisation granted pursuant to the Medical Preparations (Licensing and Sale) Regulations, 1996,

"wholesale licence" means a licence granted pursuant to the Medical Preparations (Wholesale Licences) Regulations 1993-1996.

3. Subject to Article 4 hereof, there shall be paid to the Board in respect of each and every matter set out in column 1 of the schedule hereto the fee as set out in column 2 of the said Schedule.

4. The Board may, in circumstances where it considers it appropriate to do so, waive, remit or refund, either in whole or in part, any fee that would otherwise be payable to it under Article 3 hereof.

5. These Regulations shall come into operation on the 19th day of February, 1996.

SCHEDULE

COLUMN 1

COLUMN 2

Application for Product Authorisation

£

Full Dossier — Complex

National application

6,000.00

Each additional form (at same time)

2,500.00

Each additional strength (at same time)

320.00

Incoming decentralised

4,200.00

Each addition form (at same time)

1,800.00

Each additional strength (at same time)

320.00

Outgoing decentralised supplement

2,500.00

Reduced Dossier — Complex

National application

4,500.00

Each additional form (at same time)

2,500.00

Each additional strength (at same time)

320.00

Incoming decentralised

3,200.00

Each additional form (at same time)

1,600.00

Each additional strength (at same time)

320.00

Outgoing decentralised supplement

2,500.00

Reduced Dossier — Standard

National application

3,000.00

Each additional form (at same time)

2,500.00

Each additional strength (at same time)

320.00

Incoming decentralised

2,100.00

Each additional form (at same time)

1,400.00

Each additional strength (at same time)

320.00

Outgoing decentralised supplement

1,500.00

Subsequent extension applications

First additional form

3,000.00

Each additional form (at same time)

2,500.00

First additional strength (existing form)

1,350.00

Each additional strength (at same time)

320.00

Outgoing decentralised supplement

—additional form

1,400.00

—additional strength

320.00

Variation of product authorisation

Simple variation

—national

240.00

—outgoing decentralised supplement

210.00

Complex variation

—national

1,600.00

—outgoing decentralised supplement

325.00

Change of ownership

—related company

550.00

—non-related company

1,450.00

Maintenance of product authorisation

First strength in each form

— annual fee

290.00

each additional strength

— annual fee

75.00

Homoeopathic Registration

Application

360.00

Wholesale Licence

Annual Fee

—Main site

850.00

—each additional site

350.00

—minor site

250.00

Variation to licence

—administrative

80.00

—technical

240.00

Manufacturing Licence

Annual fee

—Major site (>250 employees)

4,500.00

—Large site (150—250 employees)

3,000.00

—Medium site (50—149 employees)

2,000.00

—small site (

1,000.00

Variation to licence

—administrative

80.00

—technical

240.00

DATED this 13th day of February, 1996.

BRIAN O'SHEA,

Minister of State at the Department of Health.

EXPLANATORY NOTE.

The purpose of these Regulations is to provide for the payment of fees to the Irish Medicines Board pursuant to section 13 of the Irish Medicines Board Act, 1995 .